NO943645L - Enantiomerisk 1-fenyl-2-(2-pyridinyl)etylamin for behandling av neurodegenerative forstyrrelser - Google Patents
Enantiomerisk 1-fenyl-2-(2-pyridinyl)etylamin for behandling av neurodegenerative forstyrrelserInfo
- Publication number
- NO943645L NO943645L NO943645A NO943645A NO943645L NO 943645 L NO943645 L NO 943645L NO 943645 A NO943645 A NO 943645A NO 943645 A NO943645 A NO 943645A NO 943645 L NO943645 L NO 943645L
- Authority
- NO
- Norway
- Prior art keywords
- phenyl
- treatment
- neurodegenerative disorders
- enantiomeric
- ethylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929207339A GB9207339D0 (en) | 1992-04-03 | 1992-04-03 | Pharmaceutical compound |
| GB929208290A GB9208290D0 (en) | 1992-04-15 | 1992-04-15 | Pharmaceutical compound having neuroprotective properties |
| PCT/GB1993/000689 WO1993020052A1 (en) | 1992-04-03 | 1993-04-01 | Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO943645D0 NO943645D0 (no) | 1994-09-30 |
| NO943645L true NO943645L (no) | 1994-11-16 |
| NO302170B1 NO302170B1 (no) | 1998-02-02 |
Family
ID=26300643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO943645A NO302170B1 (no) | 1992-04-03 | 1994-09-30 | Enantiomerisk 1-fenyl-2-(2-pyridinyl)etylamin, farmasöytisk formulering og anvendelse derav |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP0633879B1 (no) |
| JP (2) | JP3120810B2 (no) |
| KR (1) | KR100259567B1 (no) |
| CN (1) | CN1044367C (no) |
| AT (1) | ATE163925T1 (no) |
| AU (2) | AU3897693A (no) |
| CA (1) | CA2133427C (no) |
| CZ (1) | CZ288519B6 (no) |
| DE (1) | DE69317411T2 (no) |
| DK (1) | DK0633879T3 (no) |
| DZ (1) | DZ1677A1 (no) |
| ES (1) | ES2115055T3 (no) |
| FI (1) | FI105025B (no) |
| HU (1) | HU211529A9 (no) |
| IL (1) | IL105276A (no) |
| MA (1) | MA22866A1 (no) |
| MX (1) | MX9301935A (no) |
| MY (1) | MY110149A (no) |
| NO (1) | NO302170B1 (no) |
| NZ (1) | NZ251384A (no) |
| PL (1) | PL180014B1 (no) |
| RU (1) | RU2128650C1 (no) |
| SG (1) | SG47948A1 (no) |
| SK (1) | SK281258B6 (no) |
| TW (1) | TW282455B (no) |
| UA (1) | UA29437C2 (no) |
| WO (1) | WO1993020052A1 (no) |
| ZA (1) | ZA932415B (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9320273D0 (en) | 1993-04-01 | 1993-11-17 | Fisons Corp | Compound useful in therapy |
| EP0648489A1 (en) * | 1988-08-12 | 1995-04-19 | Fisons Corporation | Arylalkylamides having neuroprotective properties |
| ZA942140B (en) * | 1993-04-01 | 1994-10-03 | Fisons Corp | Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy |
| SE9901077D0 (sv) * | 1999-03-23 | 1999-03-23 | Astra Ab | Novel use |
| SE9901237D0 (sv) * | 1999-04-06 | 1999-04-06 | Astra Ab | Novel use |
| SE9901340D0 (sv) | 1999-04-15 | 1999-04-15 | Astra Pharma Prod | Novel process |
| NZ516782A (en) * | 1999-07-28 | 2004-12-24 | Ortho Mcneil Pharm Inc | Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| WO2007017652A2 (en) * | 2005-08-10 | 2007-02-15 | Astrazeneca Ab | Arylakylamines for the treatment of cancer |
| EA201190064A1 (ru) | 2008-12-24 | 2012-02-28 | Астразенека Аб | Соединения этанамина и их применение для лечения депрессии |
| JP2015501652A (ja) * | 2011-12-14 | 2015-01-19 | アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag | Gabr−a2診断 |
| RS58991B1 (sr) | 2013-11-05 | 2019-08-30 | Astrazeneca Ab | Prolekovi nmda antagonista |
| WO2021262779A1 (en) * | 2020-06-23 | 2021-12-30 | Biohaven Therapeutics Ltd. | Topical formulations of (1s)-1-phenyl-2-pyridin-2-ylethanamine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK689388A (da) * | 1987-12-11 | 1989-06-12 | Syntex Lab | Anvendelse af dihydropyridinderivater |
| EP0648489A1 (en) * | 1988-08-12 | 1995-04-19 | Fisons Corporation | Arylalkylamides having neuroprotective properties |
-
1993
- 1993-04-01 EP EP93907975A patent/EP0633879B1/en not_active Expired - Lifetime
- 1993-04-01 CA CA002133427A patent/CA2133427C/en not_active Expired - Lifetime
- 1993-04-01 AT AT93907975T patent/ATE163925T1/de active
- 1993-04-01 SK SK1177-94A patent/SK281258B6/sk not_active IP Right Cessation
- 1993-04-01 AU AU38976/93A patent/AU3897693A/en not_active Abandoned
- 1993-04-01 JP JP05517251A patent/JP3120810B2/ja not_active Expired - Lifetime
- 1993-04-01 ES ES93907975T patent/ES2115055T3/es not_active Expired - Lifetime
- 1993-04-01 DE DE69317411T patent/DE69317411T2/de not_active Expired - Lifetime
- 1993-04-01 DK DK93907975T patent/DK0633879T3/da active
- 1993-04-01 PL PL93305404A patent/PL180014B1/pl unknown
- 1993-04-01 SG SG1996005610A patent/SG47948A1/en unknown
- 1993-04-01 RU RU94042465A patent/RU2128650C1/ru active
- 1993-04-01 NZ NZ251384A patent/NZ251384A/en not_active IP Right Cessation
- 1993-04-01 WO PCT/GB1993/000689 patent/WO1993020052A1/en not_active Ceased
- 1993-04-01 UA UA94095853A patent/UA29437C2/uk unknown
- 1993-04-01 KR KR1019940703465A patent/KR100259567B1/ko not_active Expired - Lifetime
- 1993-04-01 CZ CZ19942409A patent/CZ288519B6/cs not_active IP Right Cessation
- 1993-04-02 IL IL105276A patent/IL105276A/xx not_active IP Right Cessation
- 1993-04-02 ZA ZA932415A patent/ZA932415B/xx unknown
- 1993-04-02 MY MYPI93000602A patent/MY110149A/en unknown
- 1993-04-02 MX MX9301935A patent/MX9301935A/es unknown
- 1993-04-02 MA MA23157A patent/MA22866A1/fr unknown
- 1993-04-03 DZ DZ930038A patent/DZ1677A1/fr active
- 1993-04-03 CN CN93104534A patent/CN1044367C/zh not_active Expired - Lifetime
- 1993-04-30 TW TW082103364A patent/TW282455B/zh not_active IP Right Cessation
-
1994
- 1994-09-30 FI FI944546A patent/FI105025B/fi not_active IP Right Cessation
- 1994-09-30 NO NO943645A patent/NO302170B1/no not_active IP Right Cessation
-
1995
- 1995-06-13 HU HU95P/P00192P patent/HU211529A9/hu unknown
-
1996
- 1996-12-18 AU AU75456/96A patent/AU705419B2/en not_active Expired
-
2000
- 2000-05-30 JP JP2000159319A patent/JP2000319259A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI954979A7 (fi) | Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset | |
| ITMI940326A0 (it) | Derivati del 3,8-diazabiciclo[3.2.1.]lottano ad attivita' analgesica | |
| CA2180535A1 (en) | A method for treatment of psoriasis, by omeprazole or related compounds | |
| AU6563596A (en) | Treatment of tinnitis using neuroprotective agents | |
| NO943645L (no) | Enantiomerisk 1-fenyl-2-(2-pyridinyl)etylamin for behandling av neurodegenerative forstyrrelser | |
| WO1993000094A3 (en) | Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine | |
| NO912797L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme karbostirilderivater. | |
| IT1290781B1 (it) | Agente attivo terapeutico per il trattamento di malattie degenerative neuronali. | |
| MA24130A1 (fr) | PROCEDE DE PREPARATION D'ENANTIOMERES PURS D'ACIDES CYCLO-ALCANO-INDOLAZAINDOL ET PYRIMIDO-(1,2a) INDOL - CARBOCYCLIQUES ET LEURS DERIVES | |
| NO972449D0 (no) | Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on 1,1 dioksidderivater og preparater og fremgangsmåte for anvendelse derav | |
| CA2135709A1 (en) | Melatonin derivatives for use in treating sleep disorders | |
| ITMI931019A0 (it) | Derivati del cicloeptimmidazolo, metodo per la loro produzione e agenti terapeutici contenenti questi composti | |
| NO924290L (no) | Azabenzimidazoler for behandling av astma, artritt og lignende lidelser | |
| AU8715491A (en) | Melatonin derivative having therapeutic activity in dermatology | |
| AU6581294A (en) | Ethanolamine derivatives useful for the treatment of gastrointestinal disorders | |
| AU647608B2 (en) | Isoxazolylimidazole derivatives, process for their production and their use in pharmaceutical agents | |
| IT1276321B1 (it) | Derivati del carbossimetilidenecicloptimmidazolo procedimento di fabbricazione dei derivati e agenti terapeutici che contengono | |
| RU95122486A (ru) | Средство для лечения тикозных гиперкинезов | |
| RU95111888A (ru) | Способ лечения периферических поражений лицевого нерва | |
| AU8701298A (en) | 2,3-dihydro-benzofuranol derivatives and process for resolving the same | |
| IT1263076B (it) | Uso orale e topico della n-acetil-5-metossitriptamina (melatonina) nella terapia della psoriasi volgare. | |
| FI20040505A7 (fi) | Menetelmä 1,3-dihydro-6-hydroksi-2H-indol-2-oni-johdannaisten valmistamiseksi | |
| ITMI921770A1 (it) | Composizioni farmaceutiche atte al trattamento dei disturbi della memoria. | |
| ITMI931684A1 (it) | Procedimento per la preparazione di derivati del 3, 4-diidrocarbostirile | |
| ES1021895Y (es) | Figura de centauro articulada, perfeccionada. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |